Takhzyro Approved for Pediatric Hereditary Angioedema
The approval was supported extrapolation of efficacy data from the phase 3 HELP study, along with safety and pharmacodynamic data from the phase 3 SPRING study.
Diagnosis & Disease Information
Odactra Approved for Adolescents With House Dust Mite Allergic Rhinitis
Odactra is an allergen extract indicated as immunotherapy for the treatment of HDM-induced allergic rhinitis.
Rotavirus Increases Risk for Neurologic Disease, Poor Outcomes in Pediatric Patients
Researchers evaluated whether there is an association between rotavirus infection and extraintestinal complications in pediatric patients.
Adacel Approved for Use During Pregnancy to Prevent Pertussis in Infants
The approval was based on a re-analysis of data from on observational study of Tdap vaccine effectiveness in the US.
Few Parents Introduce Infants to Top Food Allergens by 7 Months of Age
A survey developed by pediatricians and allergists identified current practices regarding the introduction of food allergens to children aged 7 months to 3.5 years.
COVID-19 Vaccination Plus Previous Infection Most Protective Against Reinfection
Researchers assessed protection against COVID-19 Delta and Omicron infection among adolescents who were either vaccinated, previously infected, or had hybrid immunity.
Nirsevimab Under Review for Protection Against RSV for All Infants
Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
Wegovy Gains Approval for Treating Obesity in Adolescents
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Parental Vaccination Reduces Hospitalization Risk Due to COVID-19 in Children
Researchers sought to analyze COVID-19 vaccination status among parents of hospitalized children younger than age 5 years with COVID-19 infection during the Delta and Omicron waves.
Consistent Results Observed With Topical Roflumilast in Second Atopic Dermatitis Trial
The INTEGUMENT-2 trial included patients 6 years of age and older with mild to moderate atopic dermatitis involving at least 3% body surface area.
- Loading...
Loading...
Next post in Pediatrics
Loading... 
Loading...